RecruitingNCT05838079

Copenhagen Baby Heart Study - Impact


Sponsor

Henning Bundgaard

Enrollment

35,000 participants

Start Date

Nov 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Copenhagen Baby Heart Study - Impact (CBHS-I) is an extension to Copenhagen Baby Heart (CBH) which included over 25.000 new-borns in the Copenhagen area between 2016-2018. Based on clinical and subclinical deviations in the examinations in CBH, subgroups of participants will be invited to clinical examinations (echocardiography and electrocardiogram) in early childhood. There will also be a new, targeted inclusion based on certain exposures during pregnancy. The main objectives are to assess the prevalence of congenital and inherited heart disease and, and the development of these during early childhood; examining the association between pre- and postnatal exposure, disease, lifestyle, environmental and genetic factors; continue to establish reference values for echocardiography in Danish neonates and children.


Eligibility

Min Age: 1 DayMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Clinical examination for people with congenital heart disease. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClinical examination

Echocardiography Electrocardiography Analysis of umbilical and/or venous blood. Peripheral measurement of oxygen saturation


Locations(3)

Rigshospitalet Copenhagen University Hospital.

Copenhagen Ø, Denmark

Herlev and Gentofte Hospital

Herlev, Denmark

Hvidovre Hospital

Hvidovre, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05838079


Related Trials